EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box

Samuele Risoli iD, Cristina Nali iD, Sabrina Sarrocco iD, Arrigo Francesco Giuseppe Cicero iD, Alessandro Colletti, Filippo Bosco, Giuseppe Venturella iD, Agata Gadaleta iD, Maria Letizia Gargano iD, Ilaria Marcotuli iD

Nutrients · 02.02.2023 · 15 (3) · 776

DOI: 10.3390/nu15030776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 02.02.2023. Verfasst von Samuele Risoli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agriculture, Food and Environment, University of Pisa, Via del Borghetto 80, 56124 Pisa, Italy. Hauptthemen laut MEDLINE: Agaricales, Reishi. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mushrooms and derivates are well known to the scientific community for having different health benefits and exhibit a wide range of pharmacological activities, including lipid-lowering, antihypertensive, antidiabetic, antimicrobic, antiallergic, anti-inflammatory, anticancer, immunomodulating, neuroprotective and osteoprotective actions. In Europe, medical mushrooms are mainly marketed in the form of food supplements as single components or combined with other nutraceuticals. In this context, the first peculiarity that distinguishes it is the safety established through the “history of consumption” that characterizes that mushroom. However, the cultivation of medicinal mushrooms on a large scale is performed mainly in China, where most of the production facilities do not have internationally recognized good manufacturing practices, despite that many European companies that sell myotherapies are supplied by Chinese manufacturers. This is particularly evident in Italy, where an arsenal of mushroom products is marketed in the form of powders and extracts not always of ascertained origin and sometimes of doubtful taxonomic identification, and thus not meeting the quality criteria required. The growing interest in mycotherapy involves a strong commitment from the scientific community to propose supplements of safe origin and genetic purity as well as to promote clinical trials to evaluate its real effects on humans. The purpose of this research is to analyze different mushroom-based dietary supplements used in medicine as monotherapy on the Italian market and to evaluate their composition and quality. The molecular identification of the sequences with those deposited in GenBank allowed for identifying 6 out of 19 samples, matching with those deposited belonging to the species indicated in the label, i.e., Lentinula edodes (samples 1, 4, 12 and 18) and Ganoderma lucidum (samples 5 and 10). Samples containing Ganoderma, labeled in the commercial product as G. lucidum, showed sequences that showed homology of 100% and 99% with G. resinaceum and G. sichuanense. An additional investigation was carried out in order to determine the active fungal ingredients, such as ergosterol, aflatoxins, heavy metals, nicotine and total glucan. The results obtained and shown in the manuscript highlight how the data were not only in line with what is expected with respect to what is indicated in the labels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgaricalesReishiHumansDietary SupplementsItalyEurope

Stichwörter der Autor:innen

Agaricus blazeifunctional foodsmushroomsnutraceuticalsnutritional supplementsqualityreishishiitake

Autor:innen und Institutionen

  • Department of Agriculture, Food and Environment, University of Pisa, Via del Borghetto 80, 56124 Pisa, Italy.
  • Nutrafood Research Center, University of Pisa, Via del Borghetto 50, 56124 Pisa, Italy.
  • Medical and Surgical Sciences Department, University of Bologna, 40126 Bologna, Italy.
  • IRCCS AOU S. Orsola di Bologna, 40126 Bologna, Italy.
  • Department of Drug Science and Technology, University of Torino, 10124 Torino, Italy.
  • U.O. Anesthesia and Intensive Care MiSC, AOUP Complementary Medicine Oncology Integrated, University Hospital Trust of Pisa, 56126 Pisa, Italy.

ORCID-Profile: Samuele Risoli, Cristina Nali, Sabrina Sarrocco, Arrigo Francesco Giuseppe Cicero, Giuseppe Venturella, Agata Gadaleta, Maria Letizia Gargano, Ilaria Marcotuli

Zitieren

APA

Risoli, S., Nali, C., Sarrocco, S., Cicero, A. F. G., Colletti, A., Bosco, F., Venturella, G., Gadaleta, A., Gargano, M. L., & Marcotuli, I. (2023). Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box. Nutrients, 15(3), 776. https://doi.org/10.3390/nu15030776

Vancouver

Risoli S, Nali C, Sarrocco S, Cicero AFG, Colletti A, Bosco F, et al. Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box. Nutrients. 2023;15(3):776. doi:10.3390/nu15030776

BibTeX
@article{Risoli2023,
  author = {Risoli, Samuele and Nali, Cristina and Sarrocco, Sabrina and Cicero, Arrigo Francesco Giuseppe and Colletti, Alessandro and Bosco, Filippo and Venturella, Giuseppe and Gadaleta, Agata and Gargano, Maria Letizia and Marcotuli, Ilaria},
  title = {Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {776},
  doi = {10.3390/nu15030776}
}
Kostenlos starten →